Optimal Ablation Volumes Are Achieved at Submaximal Power Settings in a 2.45-GHz Microwave Ablation System
- 3 June 2014
- journal article
- research article
- Published by SAGE Publications in Surgical Innovation
- Vol. 22 (1) , 41-45
Abstract
Introduction. Local ablative therapies, including microwave ablation (MWA), are common treatment modalities for in situ tumor destruction. Currently, 2.45-GHz ablation systems are gaining prominence because of the shorter application times required. The aims of this study were to determine optimal power and time to ablation volume (AbV) ratios for a new 1.8-mm–2.45-GHz antenna using ex vivo tissue models. Methods. The 1.8-mm–2.45-GHz Accu2i MWA system was employed to perform ablations in bovine liver, porcine muscle, and porcine kidney ex vivo. Whole tissues were prewarmed (35°C) and multiple ablations performed at power settings of 60 to 180 W for 2- to 6-minute time intervals. Postablation, tissues were dissected, AbVs calculated, and correlations to power and time settings made. Results. Significant increases in AbV were measured between each of the time points for a constant power setting in all 3 tissues. Increasing power settings led to significant increases in AbV at power settings ≤140 W. However, no significant increase in AbV was obtained at power settings >140 W. Conclusions. Optimal efficiency for MWA using a new 1.8-mm–2.45-GHz system is achieved at settings of ≤140 W for 6 minutes in a range of ex vivo tissue and no additional benefit occurs by increasing the power setting to 180 W in these tissues.Keywords
This publication has 19 references indexed in Scilit:
- Ablation therapy for hepatocellular carcinoma: past, present and future perspectivesHepatic Oncology, 2013
- Radiologically-guided thermal ablation of renal tumoursDiagnostic and Interventional Imaging, 2012
- Ablative therapies for colorectal liver metastases: a systematic reviewColorectal Disease, 2011
- Colour doppler ultrasonography provides real-time microwave field visualisation in an ex vivo porcine modelHPB, 2011
- Radiofrequency, microwave and laser ablation of pulmonary neoplasms: Clinical studies and technical considerations—Review articleEuropean Journal of Radiology, 2011
- Hepatic Tumor AblationSurgical Clinics of North America, 2010
- Liver tumor ablation: Percutaneous and open approachesJournal of Surgical Oncology, 2009
- Hepatocellular carcinoma: new options for image‐guided ablationJournal of Hepato-Biliary-Pancreatic Sciences, 2009
- Radiofrequency and Microwave Ablation of the Liver, Lung, Kidney, and Bone: What Are the Differences?Current Problems in Diagnostic Radiology, 2009
- Tumour ablation: current role in the kidney, lung and boneCancer Imaging, 2009